Zdrowie i gospodarka · 22/05/2018

FDA Requests Public Comment on Proposed Collection of Information Related to Generic Drug Development

The Food and Drug Administration is seeking public input on a proposed collection of information related to generic drug development, as required by the Paperwork Reduction Act of 1995, and will accept comments for 60 days.